Family · Pharmaceutical analytical standards
Mizolastine
A second-generation H1 antihistamine, a benzimidazole derivative, introduced in Europe in the late 1990s (in Germany in 1998) for allergic rhinitis and urticaria; it is only mildly sedating. This family brings together the active ingredient, metabolites, labelled standards and other impurities.
Did you know?Besides blocking histamine, it is credited with anti-inflammatory properties: in the laboratory it curbs the production of leukotrienes, other mediators of allergy, by inhibiting the enzyme 5-lipoxygenase.
No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.
